Articles by Benjamin Locwin

Final Word: Regulatory Evolution

The co-evolution of the drug industry and the regulatory agencies challenges both groups
Jan 1, 2007
By: Benjamin Locwin

How much do regulatory agencies know about nanotechnology or microfluidics? Yesterday, the answer was probably, "not much." Tomorrow, it may be "a lot." The reason is that new technologies push the agencies to expand their expertise.

The Susceptibility of CAPA to Subjective Bias

Reduce risk of failure by determining CAPA based on sound scientific theory and coherent reasoning.
Jun 1, 2005
By: Benjamin Locwin

The least we can do in our industry to ensure scientific integrity in our pursuit towards effective CAPA is to have our data peer reviewed.